Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after systemic administration and apoptosis of ex vivo-infected pancreatic islet allografts and isografts

Human Gene Therapy

Volumn 8, Issue 8, 1997, Pages 955-963

  Muruve, D A ^a   Nicolson, A G ^a   Manfro, R C ^a   Strom, T B ^a   Sukhatme, V P ^a   Libermann, T A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ADENOVIRUS 5; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; LEUKEMIA CELL LINE; LIVER INJURY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; RAT;

EID: 0031007458     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.8-955     Document Type: Article

References (27)

1. BECKER, T.C., BELTRANDELRIO, H., NOEL, R.J., JOHNSON, J., and NEWGARD, C.B. (1994). Overexpression of hexokinase 1 in isolated islets of Langerhans via recombinant adenoviruses. J. Biol. Chem. 269, 21234-21238.
2. BECKER, T.C., NOEL, R.J., COATS, W.S., GOMEZ-FOIX, A.M., ALAM, T., GERARD, D.R., and NEWGARD, C.B. (1994). Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 43, 161-189.
3. BELLGRAU, D., GOLD, D., SELAWRY, H., MOORE, J., FRANZUSOFF, A., and DUKE, R.C. (1995). A role for CD95 ligand in preventing graft rejection. Nature 377, 630-632.
4. BOYD, J.M., MALSTROM, S., SUBRAMANIAN, T., VENKATESH, L.K., SCHAEPER, U., ELANGOVAN, B., D'SA-EIPPER, C., and CHINNADURAI, G. (1994). Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 79, 341-351.
5. CHENG, J., ZHOU, T., LIU, C., SHAPIRO, J.P., BRAUER, M.J., KIEFER, M.C., BARR, P.J., and MOUNTZ, J.D. (1994). Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759-1762.
6. CSETE, M.E., BENHAMOU, P.Y., DRAZAN, K.E., WU, L., MCINTEE, D.F., AFRA, R., MULLEN, Y., BUSUTTIL, R.W., and SHARED, A. (1995). Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplantation 59, 263-268.
7. DHEIN, J., WALCZAK, H., BAUMIER, C., DEBATIN, K.M., and KRAMMER, P.H. (1995). Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438-441.
8. EHL, S., HOFFMAN-ROHRER, U., NAGATA, S., HENGARTNER, H., and ZINKENAGEL, R. (1996). Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo. J. Immunol. 156, 2357-2360.
9. FALK, M.H., TRAUTH, B.C., DEBATIN, K.M., KLAS, C., GREGORY, C.D., RICKINSON, A.B., CALENDER, A., LENOIR, G.M., ELLWART, J.W., KRAMMER, P.H., and BORNKAMM, G.W. (1992). Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 79, 3300-3306.
10. GLUZMAN, Y., REICHL, H., and SOLNICK, D. (1982). Helper free adenovirus type-5 vectors. In Eukaryolic Viral Vectors. Y. Gluzman, ed. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) pp. 187-192.
11. GRAHAM, F.L. (1984). Covalently closed circles of human adenovirus DNA are infectious. EMBO J. 3, 2917-2922.
12. GRAHAM, F.L., SMILEY, J., RUSSELL, W.C., and NAIRN, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Virol. 36, 59-72.
13. GRIFFITH, T.S., BRUNNER, T., FLETCHER, S.M., GREEN, D.R., and FERGUSON, T.A. (1995). Fas ligand-induced apoptosis as a mechanism of immune-privilege. Science 270, 1189-1192.
14. HERZ, J., and GERARD, R.D. (1993). Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. 90, 2812-2816.
15. KATSIKIS, P.D., WUNDERLICH, E.S., SMITH, C.A., HERZENBERG, L.A., and HERZENBERG, L.A. (1995). Fas antigen stimulation induces marked apoptosis of T-lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181, 2029-2036.
16. LARSEN, C.P., ALEXANDER, D.Z., HENDRIX, R., RITCHIE, S.C., and PEARSON, T.C. (1995). Fas-mediated cytotoxicity. Transplantation 60, 221-224.
17. LAU, H.T., YU, M., FONTANA, A., and STOECKART, C.J. (1996). Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273, 109-112.
18. LILES, W.C., KIENER, P.A., LEDBETTER, J.A., ARUFFO, A., and KLEBANOFF, S.J. (1996). Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184, 429-440.
19. NAGATA, S., and GOLSTEIN, P. (1995). The death factor. Science 267, 1449-1456.
20. O'CONNELL, P.J., PACHECO-SILVA, A., NICKERSON, P.W., MUGGIA, R.A., BASTOS, M., RUBIN-KELLEY, V., and STROM, T.B. (1993). Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T-cell activation transcripts. J. Immunol. 150, 1093.
21. OGASAWARA, J., WATANABE-FUKUNAGA, R., ADACHI, M., MATSUZAWA, A., KASUGAI, T., KITAMURA, Y., ITOH, N., SUDA, T., and NAGATA, S. (1993). Lethal effect of the anti-Fas antibody in mice. Nature 364, 806-809.
22. RENSING-EHL, A., FREI, K., FLURY, R., MATIBA, B., MARIANI, S.M., WELLER, M., AEBISCHER, P., KRAMMER, P.H., and FONTANA, A. (1995). Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol. 25, 2253-2258.
23. STASSI, G., TODARO, M., RICHUISA, P., GIORDANO, M., MATTINA, A., SBRIGLIA, M.S., LO MONTE, A., BUSCEMI, G., GALLUZO, A., and GIORDANO, C. (1995). Expression of apoptosis-inducing CD95 (Fas/APO-1) on human b-cells sorted by flow cytometry and cultured in vitro. Transplant. Proc. 27, 3271-3275.
24. TAKAHASHI, T., TANAKA, M., BRANNAN, C.I., JENKINS, N.A., COPELAND, N.G., SUDA, T., and NAGATA, S. (1994). Generalized lymphoproliferative disease in mice caused by a point mutation in the fas ligand. Cell 76, 969-976.
25. THOMPSON, C.B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
26. WATANABE-FUKUNAGA, R., BRANNAN, C.J., ITOH, N., YONEHARA, S., COPELAND, N.G., JENKINS, N.A., and NAGATA, S. (1992). The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274-1279.
27. YAGITA, H., SEINO, K., KAYAGAKI, N., and OKUMUR, K. (1996). CD95 ligand in graft rejection. Science 379, 682.